Fundraising FoxSerif Biomedicines
Cambridge, US · 2 known investors
Find your way into Serif Biomedicines
Sign up to find every way you can get introduced to Serif Biomedicines
- Your email: who you already know at Serif Biomedicines, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Serif Biomedicines team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine. The company aims to create tailored, long-acting treatments across multiple diseases.
Founders & leadership
JR
Jacob RubensChief Executive OfficerJacob Rubens studied synthetic biology at MIT, where he earned a PhD, and has co-founded multiple biotechnology companies including Quotient Therapeutics (where he served as CEO and President) and Tessera Therapeutics (where he held chief scientific officer and innovation officer roles). He is currently CEO of Serif Biomedicines, which develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine.
Investors · 2
Flagship Pioneeringlisted by Flagship PioneeringCambridge · $500K – $10M
How we know: Flagship Pioneering's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Frequently asked questions
- What does Serif Biomedicines do?
- Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine. The company aims to create tailored, long-acting treatments across multiple diseases.
- Who are Serif Biomedicines's investors?
- Serif Biomedicines's investors include Flagship Pioneering, Modi Ventures.
- Where is Serif Biomedicines headquartered?
- Serif Biomedicines is headquartered in Cambridge, US.